| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |